Hans Christiansen: Influence Statistics

Hans Christiansen

Hans Christiansen

Department of Radiation Oncology, Hanover Medical School, Hanover, Germany. | Clinic for Radiotherapy and Special Oncology of the Hannover Medical School, Hannover, Germany. | ...


Download all Influence Scores

Hans Christiansen: Expert Impact

Concepts for which Hans Christiansen has direct influence: Prostate cancer , Breast cancer , Adjuvant radiotherapy , Rectal cancer , Acute toxicity , Transoral laser microsurgery , Kupffer cells .

Hans Christiansen: KOL impact

Concepts related to the work of other authors for which for which Hans Christiansen has influence: Breast cancer , Radiation therapy , Psma pet , Nasopharyngeal carcinoma , Transoral laser microsurgery , Squamous cell , Biochemical recurrence .

KOL Resume for Hans Christiansen

Year
2022

Department of Radiation Oncology, Hanover Medical School, Hanover, Germany.

Klinik für Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

2021

Department of Radiotherapy, Hannover Medical School, Hannover, Germany.

Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany

Klinik für Strahlentherapie u. Spezielle Onkologie, Medizinische Hochschule Hannover/MHH, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

2020

Department of Radiotherapy and Special Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

2019

Department of Radiation Oncology, Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Germany

2018

Department of Radiation Oncology, Medical School Hannover, Hannover, Germany.

Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

2017

From the Departments of *Nuclear Medicine, †Medical Physics and Radiation Protection, ‡Urology and Urological Oncology, and §Radiation and Special Oncology, Hannover Medical School, Hannover; and ∥Department of Pharmaceutical Radiochemistry, Technical University Munich, Munich, Germany.

Department of Radiotherapy, Medical School Hannover, Germany

2016

Clinics of Radiation Oncology, Hannover Medical School, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany

2015

Department of Radiation Oncology, Medical School Hannover, Hannover, Germany

Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

2014

Department of Radiotherapy and Radiation Oncology, University Medical Centre, Georg-August-University Goettingen, Goettingen, Germany

2013

Department of Pediatric Hematology and Oncology, University Medical Center Leipzig, Leipzig, Germany

Hannover Medical School Clinic of Radiation Oncology

2012

Department of Radiation Oncology, University of Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

Klinik für Strahlentherapie und spezielle Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland

2011

Departments of aRadiotherapy and Radiooncology,

Department of Radiotherapy and Radiation Oncology, University Clinic of the Georg August University, Robert-Koch-Str. 40, D-37099 Göttingen, Germany

2010

Department of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Göttingen, Germany

2009

From the Departments of Otorhinolaryngology-Head and Neck Surgery (Rödel, Matthias, Blomeyer), Radiotherapy and Radio-oncology (Wolff, Christiansen), and Medical Statistics (Jung), University of Göttingen, Göttingen, Germany.

Department of Radiotherapy and Radiooncology, University Hospital Göttingen, Robert-Koch-Straße, Germany

Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland

Prominent publications by Hans Christiansen

KOL-Index: 14827 . A quantitative imaging biomarker is desirable to provide a comprehensive measure of whole-body tumor burden in patients with metastatic prostate cancer, and to standardize the evaluation of treatment-related changes. Therefore, we evaluated whether prostate-specific membrane antigen (PSMA) ligand PET/CT may be applied to provide PSMA-derived volumetric parameters for quantification of ...
Known for Tumor Burden | Volumetric Parameters | Prostate Cancer | Psa Levels
KOL-Index: 14552 . Purpose68Ga-labeled prostate-specific membrane antigen (PSMA) ligand positron emission tomography/computed tomography (PET/CT) has shown promising results in patients with biochemical recurrence after primary therapy for prostate cancer. In this study, we evaluated the usefulness of PSMA I&T (imaging and therapy) PET/CT prior to radical prostatectomy.MethodsThe study population consisted ...
Known for Radical Prostatectomy | Psma Pet | Prostate Cancer | Seminal Vesicle
KOL-Index: 14456 . Triple-negative breast cancer (TNBC) is an aggressive form of breast carcinoma with a poor prognosis. Recent evidence suggests that some patients with TNBC harbour germ-line mutations in DNA repair genes which may render their tumours susceptible to novel therapies such as treatment with PARP inhibitors. In the present study, we have investigated a hospital-based series of 40 German ...
Known for Brca1 Brca2 | Negative Breast | Estrogen Receptors | Germline Mutations
KOL-Index: 14252 . PurposeThe aim of this study was to assess the value of dual-time point imaging in PET/CT for detection of biochemically recurrent or persistent prostate cancer, using the prostate-specific membrane antigen (PSMA) ligand [68Ga]PSMA I&T.Methods240 patients who underwent a [68Ga]PSMA I&T PET/CT in the context of biochemical relapse of prostate cancer were included in this retrospective ...
Known for Biochemical Recurrence | Prostate Cancer | Delayed Imaging | Specific Antigen
KOL-Index: 12629 . PURPOSE: To prospectively analyze hepcidin, hemojuvelin, and ferroportin-1 expression after x-irradiation of rat liver and isolated rat hepatocytes. MATERIALS AND METHODS: The treatment of the rats and this study were approved by the local committee and the public authority on animal welfare. Rat livers in vivo and isolated rat hepatocytes in vitro were irradiated. The total number of rats ...
Known for Rat Liver | Gene Expression | Irradiated Hepatocytes | Radiation Induced
KOL-Index: 12510 . PURPOSE: To evaluate the efficacy of an adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck and to show that a less invasive surgery with organ preservation in combination with radiotherapy is an alternative to a radical treatment. PATIENTS AND METHODS: Between 1987 and 2000, 208 patients with advanced squamous cell carcinoma ...
Known for Adjuvant Radiotherapy | Transoral Laser Microsurgery | Head Neck | Carcinoma Squamous
KOL-Index: 12481 . PURPOSE: To determine the patterns of progression after 68Ga prostate-specific membrane antigen (PSMA)-ligand positron emission tomography (PET)/computed tomography (CT)-guided radiation therapy (RT) for recurrent oligometastatic prostate cancer (PCa). METHODS AND MATERIALS: One hundred and eight patients with increased prostate-specific antigen levels, who received 68Ga-PSMA-ligand ...
Known for Recurrent Prostate Cancer | Ligand Pet | Patterns Progression | Radiation Therapy
KOL-Index: 12152 . OBJECTIVE: To report the oncologic and functional outcomes of transoral laser microsurgery (TLM) in the treatment of advanced laryngeal cancer. DESIGN: Prospective case series study. SETTING: Multi-institution (academic, tertiary referral centers). PATIENTS: A total of 117 patients with pathologically confirmed T2 to T4 lesions, stage III or stage IV, glottic or supraglottic carcinoma of ...
Known for Advanced Laryngeal Cancer | Transoral Laser Microsurgery | Tlm Patients | Local Control
KOL-Index: 11656 . OBJECTIVE: Acute radiation proctitis is a relevant complication of pelvic radiation. The purpose of this study was to investigate two markers of gut inflammation as non-invasive diagnostic tools to evaluate acute radiation proctitis. MATERIAL AND METHODS: Twenty patients who underwent radiotherapy for prostate cancer took part in this prospective study. Radiation-induced toxicity was ...
Known for Radiation Proctitis | Faecal Calprotectin | Prostate Cancer | Patients Radiotherapy
KOL-Index: 11560 . PurposeTo assess the differences in the target volume (TV) delineation of metachronous lymph node metastases between 68 Ga-PSMA ligand PET/CT and conventional imaging in a comparative retrospective contouring study.Patients and methodsTwenty-five patients with biochemical prostate cancer recurrence after primary prostatectomy underwent 68 Ga-PSMA ligand PET/CT in addition to conventional ...
Known for Prostate Cancer | Lymph Node | Conventional Imaging | Target Volume Delineation
KOL-Index: 11382 . BACKGROUND: Approximately 40-70% of biochemically recurrent prostate cancer (PCa) is oligorecurrent after prostate-specific membrane antigen (PSMA) positron emission tomography (PET) staging. Metastasis-directed radiotherapy (MDT) of PSMA-positive oligorecurrence is now frequently used, but the role of concurrent androgen deprivation therapy (ADT) remains unclear. OBJECTIVE: To determine ...
Known for Androgen Deprivation | Prostate Cancer | Positron Emission | Directed Radiotherapy
KOL-Index: 10699 . ObjectiveUrinary radiotracer excretion of 68Ga-Labelled prostate-specific membrane antigen (PSMA) ligands may complicate the assessment of the prostate region and differentiation of lymph nodes from ureteral activity. The aim of this study was to assess the value of delayed imaging after forced diuresis.Materials and methodsSixty-six patients underwent 68Ga-PSMA I&T PET/CT for evaluation ...
Known for Forced Diuresis | Delayed Imaging | Prostate Cancer | Image Quality
KOL-Index: 10654 . Bloom’s syndrome is a rare autosomal recessive chromosomal instability disorder with a high incidence of various types of neoplasia, including breast cancer. Whether monoallelic BLM mutations predispose to breast cancer has been a long-standing question. A nonsense mutation, p.Q548X, has recently been associated with an increased risk for breast cancer in a Russian case–control study. In ...
Known for Breast Cancer | Nonsense Mutation | Bloom Syndrome | Blm Gene
KOL-Index: 10636 . PurposeThe goal of this work was to evaluate the early efficacy of 68Ga-PSMA ligand PET/CT imaging for radiotherapy of locally recurrent and/or oligometastatic prostate cancer.Patients and methodsA total of 29 patients with biochemical recurrence received a 68Ga-PSMA ligand PET/CT for restaging of disease, followed by 3D conformal radiotherapy of metastases or intensity-modulated radiation ...
Known for Ligand Pet | Locally Recurrent | Radiotherapy Patients | Oligometastatic Prostate
KOL-Index: 10527 . Purpose[68Ga]Tris(hydroxypyridinone)(THP)-PSMA is a novel radiopharmaceutical for one-step kit-based radiolabelling, based on direct chelation of 68Ga3+ at low concentration, room temperature and over a wide pH range, using direct elution from a 68Ge/68Ga-generator. We evaluated the clinical detection rates of [68Ga]THP-PSMA PET/CT in patients with biochemically recurrent prostate cancer ...
Known for Prostate Cancer | Pet Imaging | Detection Rates | Biochemical Recurrence

Key People For Prostate Cancer

Top KOLs in the world
#1
Ahmedin M Jemal
united states breast cancer addis ababa
#2
Peter T Scardino
prostate cancer active surveillance erectile function
#3
Rebecca L Siegel
united states colorectal cancer incidence rates
#4
Johnathan I Jonathan
prostate cancer gleason score needle biopsy
#5
Philip W Kantoff
prostate cancer psma adc androgen deprivation therapy
#6
PATRICK CRAIG Walsh
prostate cancer specific antigen pathological stage

Department of Radiation Oncology, Hanover Medical School, Hanover, Germany. | Clinic for Radiotherapy and Special Oncology of the Hannover Medical School, Hannover, Germany. | Klinik für Strahlentherapie und Spezielle Onkologie, Medizinische Hochschu